The Latest Regenerative Medicine Articles from Streetwise Reports

Fiscal Year 'Reads Well' for Regenerative Medicine Company

Research Report
The firm's final quarter and full-year results are reviewed in a Ladenburg Thalmann report. read more >

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

Research Report
The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. read more >

First Cobalt Corp., Oversold, Poised for Rebound This Year?

Contributed Opinion
Peter Epstein of Epstein Research discusses the market for cobalt and profiles one company whose shares he believes could be at an attractive entry point. read more >
Showing Results: 1 to 3 of 3

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"DRRX earned a $10M milestone payment from Gilead."
– Ed Arce, H.C. Wainwright & Co.